product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Rat anti Mouse IgG2a Heavy Chain
catalog :
MCA421
quantity :
0.25 mg
price :
373 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
LO-MG2a-7
application :
ELISA
more info or order :
image
image 1 :
Published customer image: . Rat anti Mouse IgG2a antibody, clone LO-MG2a-9 ( MCA421P ) used to evaluate pathogen specific IgG2a production in mice following Trichuris muris infection by ELISA. Image caption: . E IgG2a production in na ve and T. muris infected APCmin/+ mice serum at day 42 p.i. * p et al . (2017). Chronic Trichuris muris infection causes neoplastic change in the intestine and exacerbates tumour formation in APC min/+ mice. PLoS Negl Trop Dis 11(6): e0005708 .
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
Region :
HEAVY CHAIN
ProductCode :
MCA421
Description :
Rat anti Mouse IgG2a Heavy Chain
Specificity :
IgG2a
TargetSpecies :
Mouse
Host :
Rat
Format :
Purified
Isotypes :
IgG1
Applications :
E
ApplicationTypes :
ELISA
Clone :
LO-MG2a-7
Quantity :
0.25 mg
Quantity Value :
0.25
Quantity Type :
mg
GO Accessions :
GO:0003823,GO:0002455,GO:0019731,GO:0042571,GO:0005886,GO:0016021
GOTerms :
antigen binding,humoral immune response mediated by circulating immunoglobulin,antibacterial humoral response,immunoglobulin complex, circulating,plasma membrane,integral to membrane
Uniprot Accessions :
P01863,P01865,P01864
Gene :
Igh-1a,Igh-1a,Igh-1a
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=380793, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=380793, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=380793
Entity Formats :
Biotin,FITC,HRP,Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
267
PriceEUR :
373
PriceUSD :
373 USD
PriceCHF :
406
PriceSEK :
4252
PriceNOK :
4246
PriceDKK :
2782
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.